News
-
TRI’s bio manufacturing facility unveiled
Thursday | Aug 7 2025QLD Deputy Premier Jarrod Bleijie has officially unveiled the name of Translational Research Institute's Australian-first cGMP biomedical manufacturing facility, nearing completion in Brisbane's Boggo Road Innovation Precinct.
-
Editor’s Choice: Dercos launches innovative anti-dandruff shampoo
Thursday | Aug 7 2025DERMATOLOGICAL scalp and hair expert Dercos by Vichy has released a new 2-in-1 anti-dandruff shampoo (RRP $23.99), as the brand expands its range across Australia.
-
‘Moo-ve’ over for Mudie
Thursday | Aug 7 2025A NEW affordable Gen Z fragrance brand has just launched called Mudie Cow, with plenty of personality and quirkiness.
-
New BioGaia probiotic keeps the gut healthy
Thursday | Aug 7 2025BIOGAIA has launched Gastrus Pure Action, a probiotic designed to relieve the symptoms of medically diagnosed IBS and help support normal bowel function.
-
Happy healthy hair
Thursday | Aug 7 2025KEEP hair strong and thick with L'Oreal Paris Elvive's new Growth Booster Anti-Fall Scalp Serum (RRP $32.99), formulated with aminexil, niacinamide and ginger extract to keep the scalp hydrated.
-
Dispensary Corner 07 Aug 25
Thursday | Aug 7 2025A MASSACHUSETTS woman has been left facing huge rabies vaccination bills after part of a wild bat ended up in her mouth.
-
Guild’s 10-year roadmap
Wednesday | Aug 6 2025THE Pharmacy Guild of Australia has unveiled a strategic plan that will see it position community pharmacies as the cornerstone of the nation's healthcare system (PD breaking news yesterday).
-
Arrotex/Antengene ink Xpovio deal
Wednesday | Aug 6 2025MELBOURNE-BASED Arrotex Pharmaceuticals will become the exclusive local distributor and marketing leader for blood cancer and multiple myeloma (RRMM) treatment Xpovio (selinexor).
-
CPAP may harm heart in some OSA patients
Wednesday | Aug 6 2025NEW research has shown that using continuous positive airway pressure (CPAP) to treat obstructive sleep apnoea (OSA), lowers the risk of serious cardiovascular events in some patients, but may increase the risk of cardiovascular events in others, with researchers calling for a more personalised approach to treating OSA.
-
MM2025 abstracts
Wednesday | Aug 6 2025WITH four months to go until Medicines Management 2025 (MM2025), Advanced Pharmacy Australia's (AdPHA)annual conference, the industry body has confirmed its selection of scientific abstracts (PD 02 Apr).
